Fingerprint
Dive into the research topics of 'PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer
Alexandra Hockla, Erin Miller, Moh'd A. Salameh, John A. Copland, Derek C. Radisky, Evette S. Radisky
Research output: Contribution to journal › Article › peer-review
31
Scopus
citations